User menu

An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis.

Bibliographic reference Lamba, Monika ; Bouzin, Caroline ; Weynand, Birgit ; Marbaix, Etienne. An Appraisal of Proliferation and Apoptotic Markers in Papillary Thyroid Carcinoma: An Automated Analysis.. In: PLoS One, Vol. 11, no. 2, p. e0148656 [1-15] (2016)
Permanent URL
  1. Davies Louise, Welch H. Gilbert, Increasing Incidence of Thyroid Cancer in the United States, 1973-2002, 10.1001/jama.295.18.2164
  2. Saiz Antonio D., Olvera Maria, Rezk Sherif, Florentine Barbara A., McCourty Althea, Brynes Russell K., Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions, 10.1002/path.1185
  3. Ito Yasuhiro, Miyauchi Akira, Kakudo Kennichi, Hirokawa Mitsuyoshi, Kobayashi Kaoru, Miya Akihiro, Prognostic Significance of Ki-67 Labeling Index in Papillary Thyroid Carcinoma, 10.1007/s00268-010-0746-3
  4. Song Qingbin, Wang Deguang, Lou Yi, Li Changsi, Fang Changqing, He Xiangmin, Li Jianhua, Diagnostic significance of CK19, TG, Ki67 and galectin-3 expression for papillary thyroid carcinoma in the northeastern region of China, 10.1186/1746-1596-6-126
  5. G Aune, Int J Clin Exp Pathol, 4, 444 (2011)
  6. Ribalta Teresa, McCutcheon Ian E, Aldape Kenneth D, Bruner Janet M, Fuller Gregory N, The Mitosis-Specific Antibody Anti-Phosphohistone-H3 (PHH3) Facilitates Rapid Reliable Grading of Meningiomas According to WHO 2000 Criteria : , 10.1097/01.pas.0000141389.06925.d5
  7. Tsuta Koji, Liu Diane C., Kalhor Neda, Wistuba Ignacio I., Moran Cesar A., Using the Mitosis-Specific Marker Anti–Phosphohistone H3 to Assess Mitosis in Pulmonary Neuroendocrine Carcinomas, 10.1309/ajcpdxfopxgef0rp
  8. Arora Nimmi, Scognamiglio Theresa, Lubitz Carrie C., Moo Tracy A., Kato Meredith A., Zhu Baixin, Zarnegar Rasa, Chen Yao-Tseng, Fahey Thomas J., Identification of borderline thyroid tumors by gene expression array analysis, 10.1002/cncr.24616
  9. Fusco Alfredo, Chiappetta Gennaro, Hui Pei, Garcia-Rostan Ginesa, Golden Lauren, Kinder Barbara K., Dillon Deborah A., Giuliano Ada, Cirafici Anna Maria, Santoro Massimo, Rosai Juan, Tallini Giovanni, Assessment of RET/PTC Oncogene Activation and Clonality in Thyroid Nodules with Incomplete Morphological Evidence of Papillary Carcinoma, 10.1016/s0002-9440(10)61164-9
  10. Fotedar Rati, Diederich Ludger, Fotedar Arun, Apoptosis and the cell cycle, Progress in Cell Cycle Research (1996) ISBN:9781461376934 p.147-163, 10.1007/978-1-4615-5873-6_15
  11. Pucci Bruna, Kasten Margaret, Giordano Antonio, Cell Cycle and Apoptosis, 10.1038/sj.neo.7900101
  12. Slee Elizabeth A., Adrain Colin, Martin Seamus J., Executioner Caspase-3, -6, and -7 Perform Distinct, Non-redundant Roles during the Demolition Phase of Apoptosis, 10.1074/jbc.m008363200
  13. Duan W Rachel, Garner Debra S, Williams Steven D, Funckes-Shippy Christie L, Spath Iwona S, Blomme Eric AG, Comparison of immunohistochemistry for activated caspase-3 and cleaved cytokeratin 18 with the TUNEL method for quantification of apoptosis in histological sections of PC-3 subcutaneous xenografts, 10.1002/path.1289
  14. TM Mishunina, Exp Oncol, 32, 269 (2010)
  15. Czabotar Peter E., Lessene Guillaume, Strasser Andreas, Adams Jerry M., Control of apoptosis by the BCL-2 protein family: implications for physiology and therapy, 10.1038/nrm3722
  16. Aksoy M., Giles Y., Kapran Y., Terzioglu T., Tezelman S., Expression of bcl-2 in Papillary Thyroid Cancers and its Prognostic Value, 10.1080/00015458.2005.11679794
  17. Cvejic D, Selemetjev S, Savin S, Paunovic I, Tatic S, Changes in the balance between proliferation and apoptosis during the progression of malignancy in thyroid tumours, 10.4081/ejh.2009.e8
  18. Ghaznavi Farzad, Evans Andrew, Madabhushi Anant, Feldman Michael, Digital Imaging in Pathology: Whole-Slide Imaging and Beyond, 10.1146/annurev-pathol-011811-120902
  19. C Bouzin, Histopathology (2015)
  20. Wolff Antonio C., Hammond M. Elizabeth H., Hicks David G., Dowsett Mitch, McShane Lisa M., Allison Kimberly H., Allred Donald C., Bartlett John M.S., Bilous Michael, Fitzgibbons Patrick, Hanna Wedad, Jenkins Robert B., Mangu Pamela B., Paik Soonmyung, Perez Edith A., Press Michael F., Spears Patricia A., Vance Gail H., Viale Giuseppe, Hayes Daniel F., Recommendations for Human Epidermal Growth Factor Receptor 2 Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Clinical Practice Guideline Update, 10.5858/arpa.2013-0953-sa
  21. Lamba Saini Monika, Weynand Birgit, Rahier Jacques, Mourad Michel, Hamoir Marc, Marbaix Etienne, Cyclin D1 in well differentiated thyroid tumour of uncertain malignant potential, 10.1186/s13000-015-0262-8
  22. Williams E. Dillwyn, , Guest Editorial: Two Proposals Regarding the Terminology of Thyroid Tumors, 10.1177/106689690000800304
  23. Baloch Z. W, LiVolsi V. A, Our approach to follicular-patterned lesions of the thyroid, 10.1136/jcp.2006.038604
  24. Chan John K.C., Strict Criteria Should Be Applied in the Diagnosis of Encapsulated Follicular Variant of Papillary Thyroid Carcinoma, 10.1309/p7ql-16kq-qlf4-xw0m
  25. R. V. DeLellis RAL (2004)
  26. van de Schepop H A. M., de Jong J. S, van Diest P. J, Baak J. P A, Counting of apoptotic cells: a methodological study in invasive breast cancer, 10.1136/mp.49.4.m214
  27. Kayser Gian, Kayser Klaus, Quantitative pathology in virtual microscopy: History, applications, perspectives, 10.1016/j.acthis.2012.12.002
  28. Hamilton Peter W., Bankhead Peter, Wang Yinhai, Hutchinson Ryan, Kieran Declan, McArt Darragh G., James Jacqueline, Salto-Tellez Manuel, Digital pathology and image analysis in tissue biomarker research, 10.1016/j.ymeth.2014.06.015
  29. R Ghossein, Arch Pathol Lab Med, 133, 683 (2009)
  30. Juan Gloria, Traganos Frank, James William M., Ray Jill M., Roberge Michel, Sauve Debra M., Anderson Hilary, Darzynkiewicz Zbigniew, Histone H3 phosphorylation and expression of cyclins A and B1 measured in individual cells during their progression through G2 and mitosis, 10.1002/(sici)1097-0320(19980601)32:2<71::aid-cyto1>;2-h
  31. Nasr Michel R, El-Zammar Ola, Comparison of pHH3, Ki-67, and Survivin Immunoreactivity in Benign and Malignant Melanocytic Lesions : , 10.1097/dad.0b013e3181624054
  32. Telu Kelly H., Abbaoui Besma, Thomas-Ahner Jennifer M., Zynger Debra L., Clinton Steven K., Freitas Michael A., Mortazavi Amir, Alterations of Histone H1 Phosphorylation During Bladder Carcinogenesis, 10.1021/pr400143x
  33. Skaland Ivar, Janssen Emiel A M, Gudlaugsson Einar, Klos Jan, Kjellevold Kjell H, Søiland Håvard, Baak Jan P A, Phosphohistone H3 expression has much stronger prognostic value than classical prognosticators in invasive lymph node-negative breast cancer patients less than 55 years of age, 10.1038/modpathol.3800972
  34. Liu Jeffrey, Singh Bhuvanesh, Tallini Giovanni, Carlson Diane L., Katabi Nora, Shaha Ashok, Tuttle R. Michael, Ghossein Ronald A., Follicular variant of papillary thyroid carcinoma : A clinicopathologic study of a problematic entity, 10.1002/cncr.22138
  35. Perisanidis Christos, Perisanidis Beata, Wrba Fritz, Brandstetter Anita, El Gazzar Sabine, Papadogeorgakis Nikolaos, Seemann Rudolf, Ewers Rolf, Kyzas Panayiotis A., Filipits Martin, Evaluation of immunohistochemical expression of p53, p21, p27, cyclin D1, and Ki67 in oral and oropharyngeal squamous cell carcinoma : p53, p21, p27, cyclin D1, and Ki67 in OOSCC, 10.1111/j.1600-0714.2011.01071.x
  36. Khoo Mark L. C., Ezzat Shereen, Freeman Jeremy L., Asa Sylvia L., Cyclin D1 Protein Expression Predicts Metastatic Behavior in Thyroid Papillary Microcarcinomas But Is Not Associated with Gene Amplification, 10.1210/jcem.87.4.8352
  37. S Fischer, Arch Pathol Lab Med, 132, 359 (2008)
  38. Wang Songtao, Lloyd Ricardo V., Hutzler Michael J., Safran Marjorie S., Patwardhan Nilima A., Khan Ashraf, The Role of Cell Cycle Regulatory Protein, Cyclin D1, in the Progression of Thyroid Cancer, 10.1038/modpathol.3880157
  39. Trovisco Vítor, Soares Paula, Preto Ana, Castro Patrícia, Máximo Valdemar, Sobrinho-Simões Manuel, Molecular genetics of papillary thyroid carcinoma: great expectations..., 10.1590/s0004-27302007000500002
  40. FA Sinicrope, Clin Cancer Res, 2, 1999 (1996)
  41. Zhang Hai-Yan, Meng Xin, Du Zhen-Xian, Fang Chang-Qing, Liu Guo-Liang, Wang Hua-Qin, Deng Wei-Wei, Significance of survivin, caspase-3, and VEGF expression in thyroid carcinoma, 10.1007/s10238-009-0031-7
  42. Saffar Hiva, Sanii Sanaz, Emami Binesh, Heshmat Ramin, Panah Vahid Hagh, Azimi Sima, Tavangar Seyed Mohammad, Evaluation of MMP2 and Caspase-3 expression in 107 cases of papillary thyroid carcinoma and its association with prognostic factors, 10.1016/j.prp.2012.06.011
  43. Tu Huacheng, Jacobs Stephen C., Borkowski Andrej, Kyprianou Natasha, Incidence of apoptosis and cell proliferation in prostate cancer: Relationship with TGF-β1 and bcl-2 expression, 10.1002/(sici)1097-0215(19961021)69:5<357::aid-ijc1>;2-4
  44. Y Furuya, Anticancer Res, 23, 577 (2003)
  45. Müller-Höcker Josef, Immunoreactivity of p53, Ki-67, and Bcl-2 in oncocytic adenomas and carcinomas of the thyroid gland, 10.1016/s0046-8177(99)90246-0
  46. Wang Wenliang, Johansson Henry, Bergholm Ulla, Wilander Erik, Grimelius Lars, Apoptosis and expression of the proto-oncogenesbcl-2 and p53 and the proliferation factor Ki-67 in human medullary thyroid carcinoma, 10.1007/bf02739913
  47. S Aaltomaa, Anticancer Res, 26, 4873 (2006)
  48. S Liu, Clin Cancer Res, 7, 1716 (2001)
  49. Bassarova Assia, Nesland Jahn M., Sedloev Theophil, Danielsen Havard, Christova Svetlana, Pilomatrix carcinoma with lymph node metastases, 10.1111/j.0303-6987.2004.0178.x
  50. Wang Rui-An, Li Qin-Long, Li Zeng-Shan, Zheng Ping-Ju, Zhang Hui-Zhong, Huang Xiao-Feng, Chi Su-Min, Yang An-Gang, Cui Rutao, Apoptosis drives cancer cells proliferate and metastasize, 10.1111/j.1582-4934.2012.01663.x